SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

Streptomyces filamentosus Details: NCBI 67294, high G+C gram-positive [species]

| "Streptomyces venezuelae subsp. roseospori" (sic) Falcao de Morais et al. 1958| AS 4.1656| ATCC 19753| ATCC 23958 [[Streptomyces roseosporus]]| BCRC 13644| BCRC 13771 [[Streptomyces roseosporus]]| CBS 492.68| CBS 941.68 [[Streptomyces roseosporus]]| CCRC 13644| CCRC:13644| CGMCC 4.1871 [[Streptomyces roseosporus]]| CGMCC 4.2073 [[Streptomyces roseosporus]]| DSM 40022| DSM 40122 [[Streptomyces roseosporus]]| HAMBI 1010| IFM 1180| IFO 12767| IFO 12910 [[Streptomyces roseosporus]]| IMET 43562| ISP 5022| ISP 5122 [[Streptomyces roseosporus]]| JCM 4122| JCM 4412 [[Streptomyces roseosporus]]| JCM 4576| KCTC 9568 [[Streptomyces roseosporus]]| NBRC 12767| NBRC 12910 [[Streptomyces roseosporus]]| NCIMB 13008 [[Streptomyces roseosporus]]| NCIMB 13018| NRRL B-2114| NRRL B-5411 [[Streptomyces roseosporus]]| NRRL-ISP 5022| RIA 1034| RIA 1125 [[Streptomyces roseosporus]]| strain 4192 [[Streptomyces roseosporus]]| strain AS 4.1871 [[Streptomyces roseosporus]]| Streptomyces filamentosus| Streptomyces filamentosus Okami and Umezawa 1953 (Approved Lists 1980) emend. Lanoot et al. 2004| Streptomyces roseisporus| Streptomyces roseosporus| Streptomyces roseosporus Falcao de Morais and Dalia Maia 1961 (Approved Lists 1980)| Streptomyces venezuelae subsp. roseospori| UNIQEM 140| VKM Ac-1266

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Streptomyces filamentosus

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.04 0 1 1 1 1 1 0 %ile 99 %ile
biomesight 0.17 10 40 0 47 22.5 20 12.6 10 40 16.7 %ile 66.7 %ile

External Reference Ranges for Streptomyces filamentosus

Streptomyces filamentosus (NCBI 67294) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Streptomyces filamentosus
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 0.14 %   0.002 %  0.001 % 4.0 2864
CerbaLab 33.333 %   0 %  % 1.0 3

Symptoms Associated with Streptomyces filamentosus From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Diet Style high-fat diets 1 Studies recorded. The consensus is Decreases📓, Click for details.
Prescription - Other metformin (prescription) 1 Studies recorded. The consensus is Increases📓, Click for details.
Probiotics Prescript Assist (2018 Formula) 1 Studies recorded. The consensus is Increases📓, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)